clinical presentations of CAD include silent ischemia, stable angina pectoris, acute coronary syndrome, heart failure and sudden death. 5 The incidence of NSTE-ACS, both absolute and relative to ST elevation myocardial infarction, is increasing, probably as a result of demographic changes in the population, including progressively increasing numbers of older persons and higher rates of diabetes mellitus. 6 Current NSTE-ACS guidelines recognize the importance of early risk stratification in the management of NSTE-ACS and recommend an integrated approach to risk assessment. 7 Several model of risk scores are developed in predicting short and mid-term outcomes in patients with acute coronary syndrome and to distinguish the patients at the highest risk or an adverse outcome, who may benefit from aggressive therapies. The PURSUIT (2000) , TIMI (Thrombolysis In Myocardial Infarction) (2000) , GRACE (2003) and FRISC (2004) risk score models are well validated with this respect. Recently (2008) the HEART risk score was developed. 8 The TIMI score was derived from clinical trial databases. Although TIMI risk score is an important and validated tool for assessing prognosis but studies evaluating its association with the extent of CAD is limited. In addition to prognostic assessment, predicting the anatomical extension of CAD is potentially useful for clinical decision. The objective of our study was to determine whether the TIMI risk score correlates with the angiographic extent and severity of CAD in patients with NSTE-ACS undergoing coronary angiography Cardiology Department of Chattogram Medical College Hospital, Chattogram, Bangladesh.
Materials and Method:
Study design and patients This cross-sectional observational study was conducted on 200 Non-ST elevation ACS patients admitted in Cardiology department of Chattogram Medical College and Hospital (CMCH), Chattogram, Bangladesh for CAG during September 2017 to May 2018. Patients were included if CAG was done within one month of NSTE-ACS. Patients were excluded on the background of refusal to give consent, severe co-morbid conditions like severe uncontrolled DM, ESRD etc.
Study procedure:
All patients admitted in the Department of Cardiology, CMCH with NSTE-ACS fulfilling the inclusion criteria were considered for inclusion in the study. Informed written consent was taken from each patient before enrollment.
Meticulous history was taken and detailed clinical examination was performed and recorded in predesigned structured proforma. History was taken about chest pain, history of diabetes, hypertension, dyslipidaemia, smoking, family history of CAD, aspirin intake, prior coronary artery disease. Demographic data such as age, sex, occupation was recorded. Risk factors profile including smoking, hypertension, diabetes, dyslipidaemia and family history of CAD was noted.
Laboratory investigations Serum Troponin I, Random Blood Sugar, Fasting Lipid Profile were done. ECG: 12 lead resting ECG was done at a paper speed of 25 mm/s and 10mm standardization at admission. Serum Troponin I concentration was determined by immunometric assay within 12 hours of hospitalization. The level of troponin I >1 ng/ml was considered as positive cardiac marker. Coronary Angiography was performed by percutaneous femoral or radial approach. Coronary angiograms were obtained for each coronary vessel in e"2 projections. Analysis of the coronary angiograms were performed visually by experienced interventional cardiologists working in CMCH catheterization laboratory. The severity of the CAD was assessed by Gensini score. Gensini score >36 was considered as severe CAD.
Data analysis:
After collection data were entered into Microsoft Excel to generate a master sheet. Next, they were fed into SPSS Statistical Software (23.0 version) for data processing and analysis. Descriptive statistics were computed and presented as either means and standard deviations or median and interquartile ranges for continuous variables. Frequencies and percentages were computed for gender, risk factors (hypertension, diabetes, smoking, dyslipidaemia and family history of CAD). Chi-square test was applied to determine the proportions difference among three TIMI risk groups. Considering that both TIMI score and the Gensini score showed non-normal distribution (Kolmogorov-Smirnov test), the statistical analyses were mainly non-parametric. Aiming at assessing the association between TIMI risk scores and CAD extension, some analyses were used. First, the linear association of risk score with the Gensini score was assessed by use of Spearman correlation. Second, the Independent sample Kruskal-Wallis test was used to compare the Gensini score values among the three TIMI risk groups. Third, the receiver-operating characteristics (ROC) curve was used to test the predictive accuracy of TIMI risk score regarding the presence of obstructive CAD. Significant prediction occurred when the area under the ROC curve was statistically different from 0.5. P value of less than 0.05 was considered as significant.
Results:
The objective of our study was to determine whether the TIMI risk score correlates with the angiographic extent and severity of CAD in patients with NSTE-ACS.A total of 200 patients diagnosed with NSTE-ACS were enrolled as sample by purposive sampling method. TIMI risk score for each patient were calculated and the patients were divided into groups according to the TIMI risk score: low risk (0-2); intermediate risk (3-4) ; high risk (5-7).
Most of the study population was <65 years of age (78%). The mean age of the patients was 53.7±10.8 years (range: 37-77years) ( Table 1) . Majority (71%) of the patients were male with male to female ratio about 2.45:1 (Figure 1) . Out of 200 NSTE-ACS patients 137 (68.5%) patients were diabetic, 155 (77.5%) were hypertensive, 136 (68%) were smokers, 70 (35%) had positive family history ischemic heart disease and 83 (41.5%) were dyslipidaemic ( Figure 2 ).
Among the TIMI risk score variables: chest pain was most prevalent and involved 131 (66%) patients, followed by 107 (54%) patients used aspirin within seven days, ST segment depression >0.5 mm was observed in 98 (49%) patients, troponin I was raised in 63 (32%) and 15 (8%) patients had prior CAD (Figure 3 ).
According to CAG, out of 200 patients, 70 (35%) had two vessel CAD, 48 (24%) had normal coronary artery, 41 (20.5%) with single vessel CAD and 41 (20.5%) had three vessel CAD. Median Gensini score was 24 (IQR: 12-40.7). Among Gensini score 137(68.5%) had score < 36 (Non severe) and 63 (31.5%) had score >36 (severe CAD).
Mean age as well as patient with age e 65 years was higher in intermediate and high risk groups in comparison to low risk group. Female outnumbered the males in low risk group (Table III) . Statistically significant association was found (p <0.001).
CAD risk factors were significantly more prevalent in intermediate and high risk groups in comparison to low risk group. Statistically significant result was found (p <0.001) (Table IV) . TIMI risk score variables were significantly more prevalent in intermediate and high risk groups in comparison to low risk group (Table V) .
Mean Gensini score were 20±12.9, 31.9±15.2and 51.9±34.1, in low TIMI risk group, intermediate group and high risk group respectively and the difference of median Gensini score was statistically significant (p <0.001). Table VII shows that, angiographic severity was increased as the TIMI risk group increased, with most of the patients in non severe CAD had low TIMI risk group in contrast to most of the patients in the severe CAD group had high TIMI risk group.
The discriminator accuracy of TIMI risk score to predict significant CAD was analyzed by ROC curve. The TIMI score discriminated accurately patients with or without obstructive CAD -area under the ROC curve of 0.661; 95% CI: 0.573-0.748; p <0.001 ( Figure 6 ).
In our study correlation co-efficient between TIMI risk score and Gensini score was r=0.446 (p <0.001). We found that Gensini score was positively and significantly associated with the TIMI score ( Figure 7 ).
As shown in Table VIII , as the TIMI score increases the extent of CAD is also increased. Among the 100 patients with low risk TIMI score, majority 69 (69%) had normal angiography finding and rest 31 (31%) had single vessel disease. Patients with intermediate TIMI risk group majority (89.7%) had two vessel disease and patents with high risk TIMI score majority (81.8%) had three vessel disease. 
